skip to Main Content
Over 60% Of UK CBD Novel Food Applications Have Hit The Buffers Or Been Withdrawn

LATEST figures from the Food Standards Agency on the progress of applications for CBD products to be included in the UK Novel Food catalogue will make worrying reading for many in the industry.

The FSA says it has received 803 applications since January 1 and of these 317 have moved on to the next stage – with four having progressed through this Validation phase and on to Authorisation.

However, this still leaves some 486 outstanding, with the FSA confirming that 41 of these have been withdrawn.

What of the other 445? Well the FSA has been hard to pin down on what the situation is with these – but it does not look promising.

No Further Progress

The FSA has said that these applications are classed as ‘Incomplete’ and it initially told BusinessCann that the applicants were being given ‘at least 7 days to upload requested information’.

With the application deadline being March 31, the seven-day window is now well behind us. When pressed, the FSA added: “Companies with applications missing some information have been given a chance to upload the missing information. If this is not done these applications will not progress any further.”

With the FSA set to update the current Public List of four Validated applications, between now and June, the chances of these applications making it through the initial Administrative check now look slim.

This has not come as a surprise to Steve Oliver, Co-Founder and Director of The Canna Consultants. It has worked on Novel Food submissions for around a dozen applicants with some of these running to 500-plus pages, and costing around £500,000.

Flippant Approach

He said: “Many applicants have not taken the process seriously enough and seemed to have made no effort.

“Some thought it would be a cut-and-paste job that could be completed in an afternoon. However. It is anything but; it’s very time-consuming, involving a huge amount of work and data collection in relation to a host of topics.”

For further background on just how onerous this process can be see this earlier BusinessCann article.

The remaining 300-plus applicants will be hoping their names are the next appear on the FSA’s Public List of CBD products which will be allowed to stay on the market between now and a decision on their Authorisation.

The first instalment of this Public List was published on April 19 and currently features four bulk ingredient suppliers with some 43 products linked to these Validated applications.

Those brands with products that do not make it on to the Public List (and its On-Hold cousin – for applications which require additional safety data) are at risk of enforcement action from Trading Standards and the FSA.

Three Stages To The Novel Food Process

However Mr Oliver added: “The FSA initially promised to have this process competed by March 31 and it now it says it will be June.

“The Public List needs to be completed as quickly as possible to allow the regulators policing the market to have the certainty they need to enforce it.

“This needs to be undertaken as soon as possible. As well as the 486 who look they will fail the process we have hundreds more who have made no effort to align with any of the Novel Food process and continue to sell their products.”

The first stage of securing a Novel Food permit is the Administrative check, which is designed to ensure all the required documentation is in place, the second is Validation; ensuring it matches the requirements, including details on safety and toxicology studies and finally Authorisation.

Peter McCuskerPeter McCusker

Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.
This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

‘Our frustration continues’: CBD could be illegal next week in North Carolina as legislative hemp action stalls

ASHEVILLE — With a key deadline less than a week away, sellers of hemp and hemp-derived cannabidiol, or CBD, are growing increasingly restless that the North Carolina General Assembly hasn’t acted to remove the plant from the state’s controlled substance list. “Our frustration continues as the General Assembly cannot get this simple legislative fix done without…

Survey Shows Marijuana Use Dropping Among Colorado Teens

Marijuana consumption among Colorado high school students dropped significantly from 2019 to 2021, according to a survey conducted by the Colorado Department of Public Health and Environment. The CDPHE’s Healthy Kids Colorado Survey is conducted every other year to monitor teen drug and alcohol use, mental health, bullying, sexual activity and other adolescent issues. After contacting nearly 107,000 students…

New Jersey legalized recreational marijuana in April. Cannabis companies were soon fined for not catering to medical patients

New Jersey fined some of the U.S,’s largest marijuana companies for violating rules put in place when the state started sales of recreational pot in April. Curaleaf Holdings Inc. and four other dispensaries with locations in New Jersey processed almost 3,200 recreational sales during hours that should have been reserved for medical patients, according to state cannabis…

Senate committee moves to let intel agencies hire people who have used marijuana

The Senate Intelligence Committee has advanced legislation that would allow US intelligence agencies to hire applicants who have used marijuana in the past, according to committee aides. Language included in the committee’s annual authorization bill for the intelligence community — which passed unanimously on Wednesday — would prohibit intelligence agencies from discriminating against job applicants based solely…

More Categories

Back To Top
×Close search
Search